Abstract: Integrating Reduced‑Dose Systemic Glucocorticoids and SGLT2 Inhibition in High‑Risk IgA Nephropathy with FSGS Pattern: An Evidence‑Based Case Report

<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MQDXN445" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Abstracts

Young Talents in Internal Medicine 2026

Integrating Reduced‑Dose Systemic Glucocorticoids and SGLT2 Inhibition in High‑Risk IgA Nephropathy with FSGS Pattern: An Evidence‑Based Case Report

by Putu Agus Marciyasa

Indonesian Society of Internal Medicine

Indonesia_Putu Agus Marciyasa